Effects of suppressing glucose transporter-1 by an antisense oligodeoxynucleotide on the growth of human hepatocellular carcinoma cells.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Hepatobiliary & Pancreatic Diseases International

• Publication date

  2011-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S1499-3872(11)60010-6PMID 21269938
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Fluorodeoxyglucose-PET/CT for diagnosis of intravascular large B-cell lymphoma.

  2010cited by this paper
• Current Management of Hepatocellular Cancer

  2010cited by this paper
• Cancer Statistics, 2010

  2010cited by this paper
• Expression and significance of beta-catenin, Glut-1 and PTEN in proliferative endometrium, endometrial intraepithelial neoplasia and endometrioid adenocarcinoma.

  2010cited by this paper
• Glucose transporter Glut-1 is detectable in peri-necrotic regions in many human tumor types but not normal tissues: Study using tissue microarrays.

  2010cited by this paper
• Glut1 and Glut3 as Potential Prognostic Markers for Oral Squamous Cell Carcinoma

  2010cited by this paper
• Glucose transporter protein 1 expression in mucoepidermoid carcinoma of salivary gland: correlation with grade of malignancy

  2010cited by this paper
• Cancer Statistics, 2009

  2009cited by this paper
• GLUT1 as a therapeutic target in hepatocellular carcinoma

  2009cited by this paper
• Correlations between selected tumor markers and fluorodeoxyglucose maximal standardized uptake values in esophageal cancer.

  2009cited by this paper
• Inhibition of cell proliferation and glucose uptake in human laryngeal carcinoma cells by antisense oligonucleotides against glucose transporter‐1

  2009cited by this paper
• Regulation of Uptake of 18F-FDG by a Follicular Human Thyroid Cancer Cell Line with Mutation-Activated K-Ras

  2009cited by this paper
• Clinical Significance of FDG Single-Photon Emission Computed Tomography: Computed Tomography in the Diagnosis of Head and Neck Cancers and Study of Its Mechanism

  2008cited by this paper
• Expression of Glucose Transporter-1 and -3 in the Head and Neck Carcinoma – The Correlation of the Expression with the Biological Behaviors

  2008cited by this paper
• Regulation of the Warburg effect in early-passage breast cancer cells.

  2008cited by this paper
• Clinical implication of glucose transport and metabolism evaluated by 18F-FDG PET in hepatocellular carcinoma.

  2008cited by this paper
• Inhibitory effect of Hypoxia inducible factor-1 antisense oligonucleotide on growth of human hepatocellular carcinoma cells

  2008cited by this paper
• Cancer Statistics, 2008

  2008cited by this paper
• Liver Transplantation for Hepatocellular Carcinoma: Hangzhou Experiences

  2008cited by this paper
• Hypoxia signalling controls metabolic demand.

  2007cited by this paper
• Prognostic implications of glucose transporter protein-1 (glut-1) overexpression in bone and soft-tissue sarcomas.

  2007cited by this paper
• Cancer's molecular sweet tooth and the Warburg effect.

  2006cited by this paper
• Biologic correlates of intratumoral heterogeneity in 18F-FDG distribution with regional expression of glucose transporters and hexokinase-II in experimental tumor.

  2005cited by this paper
• Inhibition of glycolysis in cancer cells: a novel strategy to overcome drug resistance associated with mitochondrial respiratory defect and hypoxia.

  2005cited by this paper
• Estimates of cancer incidence in China for 2000 and projections for 2005.

  2005cited by this paper
• Hepatocellular carcinoma: recent trends in the United States.

  2004cited by this paper
• Orthotopic liver transplantation for patients with hepatocellular carcinoma complicated by portal vein tumor thrombi.

  2004cited by this paper
• Coexpression of glucose transporter 1 and matrix metalloproteinase-2 in human cancers.

  2002cited by this paper
• Synthesis of antisense oligonucleotide-peptide conjugate targeting to GLUT-1 in HepG-2 and MCF-7 Cells.

  2002cited by this paper
• Assessment of Glut-1 expression in cholangiocarcinoma, benign biliary lesions and hepatocellular carcinoma.

  2002cited by this paper
• Suppression of facilitative glucose transporter 1 mRNA can suppress tumor growth.

  2000cited by this paper
• Inhibition of glucose transporter gene expression by antisense nucleic acids in HL-60 leukemia cells.

  1999cited by this paper
• Antisense GLUT1 RNA suppresses the transforming phenotypes of NIH 3T3 cells transformed by N-Ras.

  1995cited by this paper
• On the origin of cancer cells.

  1956cited by this paper
• [Origin of cancer cells].

  1956cited by this paper
• Tumorigenesis and Neoplastic Progression GLUT1 Expression Is Increased in Hepatocellular Carcinoma and Promotes Tumorigenesis

  year unknowncited by this paper

• Envisioning Glucose Transporters (GLUTs and SGLTs) as Novel Intervention against Cancer: Drug Discovery Perspective and Targeting Approach.

  2024cites this paper
• Tumor Abnormality-Oriented Nanomedicine Design.

  2023cites this paper
• A Novel Microcrystalline BAY-876 Formulation Achieves Long-Acting Antitumor Activity Against Aerobic Glycolysis and Proliferation of Hepatocellular Carcinoma

  2021cites this paper
• Glioblastoma Contains Topologically Distinct Proliferative and Metabolically Defined Subpopulations of Nestin- and Glut1-Expressing Cells.

  2021cites this paper
• Glycosylated Nanoparticles for Cancer-Targeted Drug Delivery

  2020cites this paper
• Smart nanocarriers in glucose transporters-targeted delivery of anticancer drugs

  2020cites this paper
• Including the mitochondrial metabolism of l-lactate in cancer metabolic reprogramming

  2018cites this paper
• Black bean peptides inhibit glucose uptake in Caco-2 adenocarcinoma cells by blocking the expression and translocation pathway of glucose transporters

  2018cites this paper
• Dehydroascorbic Acids-modified Polymer Micelles Target Cancer Cells to Enhance Anti-tumor Efficacy of Paclitaxel

  2017cites this paper
• Apigenin inhibits the proliferation of adenoid cystic carcinoma via suppression of glucose transporter-1

  2015cites this paper
• Inhibition of glucose-transporter 1 (GLUT-1) expression reversed Warburg effect in gastric cancer cell MKN45.

  2015cites this paper
• The greedy nature of mutant RAS: a boon for drug discovery targeting cancer metabolism?

  2015cites this paper
• Roles of glucose transporter-1 and the phosphatidylinositol 3‑kinase/protein kinase B pathway in cancer radioresistance (review).

  2015cites this paper
• Co-expression of CD 147 and GLUT1 indicates radiation resistance and poor prognosis in cervical squamous cell carcinoma

  2014cites this paper
• Co-expression of CD147 and GLUT-1 indicates radiation resistance and poor prognosis in cervical squamous cell carcinoma.

  2014cites this paper
• Expression of glucose transporters in cancers.

  2013cites this paper
• Effect of Antisense Oligodeoxynucleotides Glucose Transporter-1 on Enhancement of Radiosensitivity of Laryngeal Carcinoma

  2013cites this paper
• Advances in liver-directed gene therapy for hepatocellular carcinoma by non-viral delivery systems.

  2012cites this paper